当前位置： SCI文献检索 > BMC Cardiovascular Disorders期刊下所有文献 > Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.

Abstract：

BACKGROUND:Fabry disease is caused by mutations in the α-galactosidase A (GLA) gene, which is located in X-chromosome coding for the lysosomal enzyme of GLA. Among many gene mutations, E66Q mutation is under discussion for its pathogenicity because there is no clinical report showing pathological evidence of Fabry disease with E66Q mutation. CASE PRESENTATION:A 65-year-old Japanese female was referred to our hospital for chest discomfort on effort. Transthoracic echocardiography showed severe left ventricular (LV) hypertrophy with LV outflow obstruction. Maximum LV outflow pressure gradient was 87 mmHg, and Valsalva maneuver increased the pressure gradient up to 98 mmHg. According to medical interview, one of her younger sister and a nephew died suddenly at age 42 and 36, respectively. Another younger sister also presented LV hypertrophy with outflow obstruction. Maximum LV outflow pressure gradient was 100 mmHg, and the E66Q mutation was detected similar to the case. Endomyocardial biopsy specimens presented vacuolation of cardiomyocytes, in which zebra bodies were detected by electron microscopic examination. Although the enzymatic activity of GLA was within normal range, the c. 196G>C nucleotide change, which lead to the E66Q mutation of GLA gene, was detected. We initially diagnosed her as cardiac Fabry disease based on the findings of zebra body. However, immunostaining showed few deposition of globotriaosylceramide in left ventricular myocardium, and gene mutations in the disease genes for hypertrophic cardiomyopathy (HCM), MYBPC3 and MYH6, were detected. Although the pathogenicity of the E66Q mutation cannot be ruled out, hypertrophic obstructive cardiomyopathy (HOCM) was more reasonable to explain the pathophysiology in the case. CONCLUSIONS:This is the confusable case of HOCM with Fabry disease with the GLA E66Q mutation. We have to take into consideration the possibility that some patients with the E66Q mutation may have similar histological findings of Fabry disease, and should be examed the possibility for harboring gene mutations associated with HCM.

journal_name

BMC Cardiovasc Disord

journal_title

BMC cardiovascular disorders

authors

Oikawa M,Sakamoto N,Kobayashi A,Suzuki S,Yoshihisa A,Yamaki T,Nakazato K,Suzuki H,Saitoh S,Kiko Y,Nakano H,Hayashi T,Kimura A,Takeishi Y

doi

10.1186/s12872-016-0262-y

subject

Has Abstract

pub_date

2016-05-10 00:00:00

pages

issn

1471-2261

pii

10.1186/s12872-016-0262-y

journal_volume

pub_type

杂志文章

在线工具

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.